KA/EN
Register
Medicines reference
Search
Search
Product

Eurican DAPPi-L

Favourites

Canine distemper virus + Canine adenovirus + Canine parainfluenza virus + Canine parvovirus + Leptospira canicola + Leptospira icterohaemorrhagiae · Boehringer Ingelheim Animal Health France SCS

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml (1 ml)
Reconstitute the lyophilisate with the full suspension component and inject the entire 1 ml dose subcutaneously. Give two primary doses four weeks apart from seven weeks of age. If high maternally derived antibody levels are expected and the primary course finishes before 16 weeks, give a third dose after 16 weeks of age and at least three weeks after the second dose. Give the first booster 12 months after the primary course, then every two years; in areas of high leptospirosis risk a six-month leptospirosis booster is recommended. Vaccinate only completely healthy dogs; deworm at least 10 days beforehand. Mild immediate pruritus or pain and transient swelling up to 4 cm for 1-4 days may occur; a small transient aluminium-related nodule can occur. Exceptional hypersensitivity requires symptomatic treatment. May be used during pregnancy. Decide use with other veterinary medicines case by case. Use sterile equipment not contaminated by antiseptic or disinfectant and use immediately after reconstitution. Store at 2-8 C, protect from light and do not freeze.
 · 2 doses 4 weeks apart from 7 weeks; booster at 12 months, then every 2 years		 2 doses 4 weeks apart from 7 weeks; booster at 12 months, then every 2 years Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეურიკან DHPPi2-L - საინექციო სუსპენზიის მოსამზადებელი ლიოფილიზატი და სუსპენზია
№ 339-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Eurican DAPPi-L, Suspension

(DHPPi2-L), lyophilisate and suspension, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Eurican DAPPi-L

(DHPPi2-L), lyophilisate and suspension, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label from 7 weeks: CDV, CAV-1/2, CPV and CPiV immunisation plus two-serogroup leptospirosis (Canicola, Icterohaemorrhagiae) · Subcutaneous
Care settingPreventive veterinary vaccination of a healthy dog with examination, deworming 10 days earlier and cold-chain control
vetman score 7.9/10 Good
Evidence confidence: High Georgia: Yes, veterinary · № 339-11 · Verified on 21 Oct 2026

A good, transparent EU-authorised core vaccine whose two-serogroup leptospirosis cover is narrower than current four-serogroup options. Fine where Canicola and Icterohaemorrhagiae are the main concern.

Regulatory and scientific credibility9.0/10

The exact presentation is registered in Georgia (339-11) and has a current EU authorisation and SPC in the Union Product Database.

Clinical efficacy7.0/10

The live core antigens are well supported with two-yearly core boosting after the first year, but leptospirosis cover is limited to two serogroups and a six-month leptospiral booster is advised in high-risk areas.

Safety and tolerability8.0/10

Mild immediate pain, swelling up to 4 cm for a few days and rare hypersensitivity are labelled; the SPC permits use during pregnancy.

Clinical practicality7.5/10

Two doses four weeks apart from 7 weeks, a third after 16 weeks when maternal antibody is likely, then yearly or six-monthly leptospirosis boosting add visits.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Vaccinate only completely healthy dogs and deworm at least 10 days before vaccination.
  • Leptospirosis cover is limited to Canicola and Icterohaemorrhagiae; in high-risk areas the SPC advises a six-month leptospirosis booster.
  • If maternal antibody is likely and the primary course ends before 16 weeks, give a third dose after 16 weeks and at least three weeks after the second.
  • Mild pain or itching at injection, swelling up to 4 cm for 1-4 days and a small transient nodule can occur; exceptional hypersensitivity needs symptomatic treatment.
  • Decide use with other veterinary medicines case by case. Use sterile equipment free of antiseptic or disinfectant.
  • Store at 2-8 C, protect from light, do not freeze and use immediately after reconstitution.
Assessment sources
  1. EU SPC2026
  2. Georgia NFA register 20262026
  3. WSAVA vaccination 20242024
  4. ACVIM leptospirosis consensus 20232023
  5. AAHA canine vaccination 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus4 log10 TCID50/dose Canine adenovirus2.5 log10 TCID50/dose Canine parainfluenza virus4.7 log10 TCID50/dose Canine parvovirus4.9 log10 TCID50/dose Leptospira canicola Leptospira icterohaemorrhagiae
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer (register)
Boehringer Ingelheim Animal Health France SCS, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 476, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეურიკან DHPPi2-L - საინექციო სუსპენზიის მოსამზადებელი ლიოფილიზატი და სუსპენზია
№ 339-11
Verified on: 21 Oct 2026
 EU Yes, veterinary
Verified on: 23 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Reconstitute the lyophilisate with the full suspension component and inject the entire 1 ml dose subcutaneously. Give two primary doses four weeks apart from seven weeks of age. If high maternally derived antibody levels are expected and the primary course finishes before 16 weeks, give a third dose after 16 weeks of age and at least three weeks after the second dose. Give the first booster 12 months after the primary course, then every two years; in areas of high leptospirosis risk a six-month leptospirosis booster is recommended. Vaccinate only completely healthy dogs; deworm at least 10 days beforehand. Mild immediate pruritus or pain and transient swelling up to 4 cm for 1-4 days may occur; a small transient aluminium-related nodule can occur. Exceptional hypersensitivity requires symptomatic treatment. May be used during pregnancy. Decide use with other veterinary medicines case by case. Use sterile equipment not contaminated by antiseptic or disinfectant and use immediately after reconstitution. Store at 2-8 C, protect from light and do not freeze.
 Dog Any weight Subcutaneous 2 doses 4 weeks apart from 7 weeks; booster at 12 months, then every 2 years
EU SPC
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Eurican DAPPi-L - Summary of Product Characteristics
Union Product Database, 2026

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Canine parainfluenza virus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗